/COSM
COSM Stock - Cosmos Health Inc.
Healthcare|Drug Manufacturers - Specialty & GenericNASDAQ
$0.49-3.96%
$0.02 (-3.96%) • Dec 19
39
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.16
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.54
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for COSM
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.48 – $0.49
TARGET (TP)$0.56
STOP LOSS$0.45
RISK/REWARD1:2.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta4.40
52W High$1.32
52W Low$0.28
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $54.43M | $53.38M | $50.35M | $56.24M | $55.41M |
| Gross Profit | $4.31M | $4.35M | $5.96M | $8.33M | $8.06M |
| Gross Margin | 7.9% | 8.1% | 11.8% | 14.8% | 14.5% |
| Operating Income | $-15,544,830 | $-21,831,217 | $-7,474,036 | $-4,533,404 | $2.71M |
| Net Income | $-16,183,018 | $-18,542,654 | $-13,830,371 | $-7,961,649 | $820,786 |
| Net Margin | -29.7% | -34.7% | -27.5% | -14.2% | 1.5% |
| EPS | $-1.17 | $-2.15 | $-33.16 | $-23.74 | $1.55 |
Company Overview
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
COSMBeat Rate
63%
Last 8 quarters
Avg Surprise
-271.5%
EPS vs Estimate
Beats / Misses
5/3
Last 12 quarters
Latest EPS
$-0.17
Q4 2025
EPS Surprise History
Q3 24
+71.4%
$-0.04vs$-0.14
Q3 24
+150.0%
$0.10vs$-0.20
Q3 24
+71.4%
$-0.04vs$-0.14
Q4 24
-309.1%
$-0.45vs$-0.11
Q2 25
+11.1%
$-0.08vs$-0.09
Q2 25
+133.3%
$0.01vs$-0.03
Q3 25
-700.0%
$-0.06vs$0.01
Q4 25
-1600.0%
$-0.17vs$-0.01
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 13, 2026 | — | — | — | — |
Q4 2025 | Nov 14, 2025 | $-0.01 | $-0.17 | -1600.0% | ✗ MISS |
Q3 2025 | Aug 18, 2025 | $0.01 | $-0.06 | -700.0% | ✗ MISS |
Q2 2025 | May 15, 2025 | $-0.03 | $0.01 | +133.3% | ✓ BEAT |
Q2 2025 | Apr 15, 2025 | $-0.09 | $-0.08 | +11.1% | ✓ BEAT |
Q4 2024 | Nov 14, 2024 | $-0.11 | $-0.45 | -309.1% | ✗ MISS |
Q3 2024 | Aug 20, 2024 | $-0.14 | $-0.04 | +71.4% | ✓ BEAT |
Q3 2024 | Aug 6, 2024 | $-0.20 | $0.10 | +150.0% | ✓ BEAT |
Q3 2024 | Jul 2, 2024 | $-0.14 | $-0.04 | +71.4% | ✓ BEAT |
Q4 2023 | Nov 21, 2023 | — | $-0.09 | — | — |
Q3 2023 | Aug 15, 2023 | — | $0.02 | — | — |
Q2 2023 | May 16, 2023 | — | $-0.04 | — | — |
Q2 2023 | Apr 12, 2023 | — | $-5.61 | — | — |
Q1 2023 | Mar 6, 2023 | — | $-2.15 | — | — |
Q4 2022 | Nov 14, 2022 | — | $-2.00 | — | — |
Q3 2022 | Aug 19, 2022 | — | $-23.25 | — | — |
Q2 2022 | May 18, 2022 | — | $0.29 | — | — |
Q4 2021 | Nov 16, 2021 | — | $-2.83 | — | — |
Q3 2021 | Aug 16, 2021 | — | $-3.69 | — | — |
Q2 2021 | May 18, 2021 | — | $-3.61 | — | — |
Latest News
Cosmos Health Announces Long‑Term Strategic Partnership With Prime Ledger To Digitally Transform $300M Treasury And Tokenize IP
📈 PositiveBenzinga•Dec 3, 2025, 05:23 PM
Cosmos Health Q3 Adj. EPS $(0.02) Up From $(0.34) YoY, Sales $17.110M Up From $12.411M YoY
📈 PositiveBenzinga•Nov 17, 2025, 02:17 PM
Cosmos Health Files For Mixed Shelf Of Up To $200M
➖ NeutralBenzinga•Nov 7, 2025, 10:21 PM
Cosmos Health Initiates R&D Program Leveraging Nanotechnology To Enhance Effectiveness Of Phytochemical Constituents Used In Dietary Supplement Formulas
📈 PositiveBenzinga•Oct 31, 2025, 02:48 PM
Cosmos Health Acquires An Additional $200K Worth Of Ethereum, Bringing The Company's Total Investment In ETH To $2M
📈 PositiveBenzinga•Oct 21, 2025, 04:13 PM
Cosmos Health Regains Compliance With Nasdaq
📈 PositiveBenzinga•Oct 16, 2025, 12:06 PM
Cosmos Health Purchases Additional $300K Worth Of Ethereum, Increasing Total Investment In ETH To $1.8M
📈 PositiveBenzinga•Oct 13, 2025, 06:08 PM
Cosmos Health Buys Additional $500K Worth Of Ethereum
➖ NeutralBenzinga•Oct 10, 2025, 12:03 PM
Cosmos Health's SkyPharm S.A Secures Exclusive Distribution Agreement With Diyar United For The Marketing And Sale Of Its Sky Premium Life Line Of Nutraceuticals In Kuwait; No Financial Terms Disclosed
📈 PositiveBenzinga•Oct 3, 2025, 07:59 PM
Cosmos Health CEO Issues Letter To Shareholders
➖ NeutralBenzinga•Sep 29, 2025, 12:17 PM
Cosmos Health signs Contract Manufacturing Agreement With Medical Pharmaquality S.A, Under Which Cana Will Manufacture MYCOFAGYL
📈 PositiveBenzinga•Sep 25, 2025, 12:03 PM
Cosmos Health shares are trading higher after the company commenced U.S. operations.
📈 PositiveBenzinga•Sep 22, 2025, 07:11 PM
Cosmos Health Expects Gross Margins Of ~75% And Strong Cash Flow From Sky Premium Life U.S. Operations; NOOR Collagen Alone Projected To Generate Over $12M In Annualized Revenue
📈 PositiveBenzinga•Sep 22, 2025, 12:18 PM
Cosmos Health Commences U.S. Operations With Launch Of Sky Premium Life Food Supplements Brand
📈 PositiveBenzinga•Sep 22, 2025, 12:05 PM
COSM stock has given up its prior gain. Cosmos Health shares were trading higher after signing a distribution agreement with Scientific Pharmacy LLC for its Sky Premium Life food supplement products in Oman.
➖ NeutralBenzinga•Sep 11, 2025, 12:33 PM
Cosmos Health shares are trading higher after signing a distribution agreement with Scientific Pharmacy LLC for its Sky Premium Life food supplement products in Oman.
📈 PositiveBenzinga•Sep 11, 2025, 12:03 PM
Cosmos Health Signs Distribution Agreement With Scientific Pharmacy LLC For Its Sky Premium Life Food Supplement Products In Oman
📈 PositiveBenzinga•Sep 11, 2025, 12:02 PM
Cosmos Health Q2 EPS $(0.10) Up From $(0.15) YoY, Sales $14.746M Up From $13.207M YoY
📈 PositiveBenzinga•Aug 18, 2025, 04:47 PM
Frequently Asked Questions about COSM
What is COSM's current stock price?
Cosmos Health Inc. (COSM) is currently trading at $0.49 per share. The stock has moved -3.96% today.
What is the analyst price target for COSM?
No analyst price targets are currently available for this stock.
What sector is Cosmos Health Inc. in?
Cosmos Health Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the NASDAQ exchange.
What is COSM's market cap?
Cosmos Health Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does COSM pay dividends?
No, Cosmos Health Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCASI
CASI Pharmaceuticals, Inc.
$0.81
Mkt Cap: $0.0B
CLSD
Clearside Biomedical, Inc.
$1.00
Mkt Cap: $0.0B
FEMY
Femasys Inc.
$0.86
Mkt Cap: $0.0B
IINN
Inspira Technologies Oxy B.H.N. Ltd.
$1.02
Mkt Cap: $0.0B
LSTA
Lisata Therapeutics, Inc.
$2.06
Mkt Cap: $0.0B
MTVA
MetaVia Inc.
$8.62
Mkt Cap: $0.0B
NCNA
NuCana plc
$3.56
Mkt Cap: $0.0B
NXGL
NEXGEL, Inc.
$1.62
Mkt Cap: $0.0B
PASG
Passage Bio, Inc.
$9.59
Mkt Cap: $0.0B
SCYX
SCYNEXIS, Inc.
$0.63
Mkt Cap: $0.0B
Explore stocks similar to COSM for comparison